AGL 40.43 Increased By ▲ 0.43 (1.08%)
AIRLINK 127.48 Increased By ▲ 0.44 (0.35%)
BOP 6.60 Decreased By ▼ -0.07 (-1.05%)
CNERGY 4.50 Decreased By ▼ -0.01 (-0.22%)
DCL 8.60 Increased By ▲ 0.05 (0.58%)
DFML 41.99 Increased By ▲ 0.55 (1.33%)
DGKC 87.80 Increased By ▲ 0.95 (1.09%)
FCCL 32.89 Increased By ▲ 0.61 (1.89%)
FFBL 65.00 Increased By ▲ 0.20 (0.31%)
FFL 10.32 Increased By ▲ 0.07 (0.68%)
HUBC 109.75 Increased By ▲ 0.18 (0.16%)
HUMNL 14.80 Increased By ▲ 0.12 (0.82%)
KEL 5.12 Increased By ▲ 0.07 (1.39%)
KOSM 7.55 Increased By ▲ 0.09 (1.21%)
MLCF 41.76 Increased By ▲ 0.38 (0.92%)
NBP 59.99 Decreased By ▼ -0.42 (-0.7%)
OGDC 194.85 Increased By ▲ 4.75 (2.5%)
PAEL 28.21 Increased By ▲ 0.38 (1.37%)
PIBTL 7.82 Decreased By ▼ -0.01 (-0.13%)
PPL 152.30 Increased By ▲ 2.24 (1.49%)
PRL 26.78 Decreased By ▼ -0.10 (-0.37%)
PTC 16.19 Increased By ▲ 0.12 (0.75%)
SEARL 86.02 Increased By ▲ 0.02 (0.02%)
TELE 7.62 Decreased By ▼ -0.09 (-1.17%)
TOMCL 35.50 Increased By ▲ 0.09 (0.25%)
TPLP 8.17 Increased By ▲ 0.05 (0.62%)
TREET 16.15 Decreased By ▼ -0.26 (-1.58%)
TRG 52.76 Decreased By ▼ -0.53 (-0.99%)
UNITY 26.50 Increased By ▲ 0.34 (1.3%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.4 (0.7%)
BR30 30,951 Increased By 350.6 (1.15%)
KSE100 93,896 Increased By 540.7 (0.58%)
KSE30 29,090 Increased By 159.2 (0.55%)

The Baltoro Growth Fund, one of three funds created under the United States Agency for International Development's Pakistan Private Investment Initiative (PPII), announced an investment in AGP Limited, a Pakistani pharmaceutical manufacturing company. This investment is the first under PPII and will advance the program's goal of supporting access to capital for key sectors of Pakistan's economy.
Through Baltoro's investment, AGP Limited will have access to the financial and operating resources necessary to expand the company's growth, along with significant cost-saving opportunities that will enhance the accessibility, affordability, and sustainability of pharmaceuticals in Pakistan.
Investments in the pharmaceutical industry have the potential to spur significant development. The average annual pharmaceutical expenditure per capita in Pakistan is $36, well below the global average of $1,061. As a consequence, investments in the industry are poised to produce promising financial returns for investors while also providing greater access to healthcare for ordinary Pakistanis. Baltoro's investment will also spur new job growth. The pharmaceutical industry currently employs over 100,000 people in Pakistan. This investment in AGP Limited is expected to facilitate the creation of new jobs as the company expands.-PR

Copyright Business Recorder, 2016

Comments

Comments are closed.